Global Pharmacovigilance Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Pharmacovigilance Market Size was estimated at USD 2754.20 million in 2023 and is projected to reach USD 4394.91 million by 2029, exhibiting a CAGR of 8.10% during the forecast period.
This report provides a deep insight into the global Pharmacovigilance market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacovigilance Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacovigilance market in any manner.
Global Pharmacovigilance Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences
Market Segmentation (by Type)
Chemotherapy
Contract Outsourcing
Market Segmentation (by Application)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Pharmacovigilance Market Size was estimated at USD 2754.20 million in 2023 and is projected to reach USD 4394.91 million by 2029, exhibiting a CAGR of 8.10% during the forecast period.
This report provides a deep insight into the global Pharmacovigilance market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Pharmacovigilance Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Pharmacovigilance market in any manner.
Global Pharmacovigilance Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Eli Lilly and Company
ICON
Elsevier
Chiltern
Atlantic Research Group
Mapi Group
Accenture
Clinquest Group
GSK
PRA Health Sciences
Market Segmentation (by Type)
Chemotherapy
Contract Outsourcing
Market Segmentation (by Application)
Pharma and Biotech Companies
Contract Research Organizations (CROs)
Business Process Outsourcing (BPO) Firms
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Pharmacovigilance Market
- Overview of the regional outlook of the Pharmacovigilance Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Pharmacovigilance Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Pharmacovigilance
1.2 Key Market Segments
1.2.1 Pharmacovigilance Segment by Type
1.2.2 Pharmacovigilance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacovigilance Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharmacovigilance Sales by Manufacturers (2019-2024)
3.2 Global Pharmacovigilance Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacovigilance Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacovigilance Sales Sites, Area Served, Product Type
3.6 Pharmacovigilance Market Competitive Situation and Trends
3.6.1 Pharmacovigilance Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacovigilance Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMACOVIGILANCE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Sales Market Share by Type (2019-2024)
6.3 Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacovigilance Price by Type (2019-2024)
7 PHARMACOVIGILANCE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Market Sales by Application (2019-2024)
7.3 Global Pharmacovigilance Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
8 PHARMACOVIGILANCE MARKET SEGMENTATION BY REGION
8.1 Global Pharmacovigilance Sales by Region
8.1.1 Global Pharmacovigilance Sales by Region
8.1.2 Global Pharmacovigilance Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacovigilance Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacovigilance Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacovigilance Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacovigilance Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacovigilance Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Pharmacovigilance Basic Information
9.1.2 Eli Lilly and Company Pharmacovigilance Product Overview
9.1.3 Eli Lilly and Company Pharmacovigilance Product Market Performance
9.1.4 Eli Lilly and Company Business Overview
9.1.5 Eli Lilly and Company Pharmacovigilance SWOT Analysis
9.1.6 Eli Lilly and Company Recent Developments
9.2 ICON
9.2.1 ICON Pharmacovigilance Basic Information
9.2.2 ICON Pharmacovigilance Product Overview
9.2.3 ICON Pharmacovigilance Product Market Performance
9.2.4 ICON Business Overview
9.2.5 ICON Pharmacovigilance SWOT Analysis
9.2.6 ICON Recent Developments
9.3 Elsevier
9.3.1 Elsevier Pharmacovigilance Basic Information
9.3.2 Elsevier Pharmacovigilance Product Overview
9.3.3 Elsevier Pharmacovigilance Product Market Performance
9.3.4 Elsevier Pharmacovigilance SWOT Analysis
9.3.5 Elsevier Business Overview
9.3.6 Elsevier Recent Developments
9.4 Chiltern
9.4.1 Chiltern Pharmacovigilance Basic Information
9.4.2 Chiltern Pharmacovigilance Product Overview
9.4.3 Chiltern Pharmacovigilance Product Market Performance
9.4.4 Chiltern Business Overview
9.4.5 Chiltern Recent Developments
9.5 Atlantic Research Group
9.5.1 Atlantic Research Group Pharmacovigilance Basic Information
9.5.2 Atlantic Research Group Pharmacovigilance Product Overview
9.5.3 Atlantic Research Group Pharmacovigilance Product Market Performance
9.5.4 Atlantic Research Group Business Overview
9.5.5 Atlantic Research Group Recent Developments
9.6 Mapi Group
9.6.1 Mapi Group Pharmacovigilance Basic Information
9.6.2 Mapi Group Pharmacovigilance Product Overview
9.6.3 Mapi Group Pharmacovigilance Product Market Performance
9.6.4 Mapi Group Business Overview
9.6.5 Mapi Group Recent Developments
9.7 Accenture
9.7.1 Accenture Pharmacovigilance Basic Information
9.7.2 Accenture Pharmacovigilance Product Overview
9.7.3 Accenture Pharmacovigilance Product Market Performance
9.7.4 Accenture Business Overview
9.7.5 Accenture Recent Developments
9.8 Clinquest Group
9.8.1 Clinquest Group Pharmacovigilance Basic Information
9.8.2 Clinquest Group Pharmacovigilance Product Overview
9.8.3 Clinquest Group Pharmacovigilance Product Market Performance
9.8.4 Clinquest Group Business Overview
9.8.5 Clinquest Group Recent Developments
9.9 GSK
9.9.1 GSK Pharmacovigilance Basic Information
9.9.2 GSK Pharmacovigilance Product Overview
9.9.3 GSK Pharmacovigilance Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 PRA Health Sciences
9.10.1 PRA Health Sciences Pharmacovigilance Basic Information
9.10.2 PRA Health Sciences Pharmacovigilance Product Overview
9.10.3 PRA Health Sciences Pharmacovigilance Product Market Performance
9.10.4 PRA Health Sciences Business Overview
9.10.5 PRA Health Sciences Recent Developments
10 PHARMACOVIGILANCE MARKET FORECAST BY REGION
10.1 Global Pharmacovigilance Market Size Forecast
10.2 Global Pharmacovigilance Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacovigilance Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacovigilance Market Size Forecast by Region
10.2.4 South America Pharmacovigilance Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacovigilance by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharmacovigilance Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacovigilance by Type (2025-2030)
11.1.2 Global Pharmacovigilance Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacovigilance by Type (2025-2030)
11.2 Global Pharmacovigilance Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacovigilance Sales (K Units) Forecast by Application
11.2.2 Global Pharmacovigilance Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Pharmacovigilance
1.2 Key Market Segments
1.2.1 Pharmacovigilance Segment by Type
1.2.2 Pharmacovigilance Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PHARMACOVIGILANCE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Pharmacovigilance Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Pharmacovigilance Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PHARMACOVIGILANCE MARKET COMPETITIVE LANDSCAPE
3.1 Global Pharmacovigilance Sales by Manufacturers (2019-2024)
3.2 Global Pharmacovigilance Revenue Market Share by Manufacturers (2019-2024)
3.3 Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Pharmacovigilance Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Pharmacovigilance Sales Sites, Area Served, Product Type
3.6 Pharmacovigilance Market Competitive Situation and Trends
3.6.1 Pharmacovigilance Market Concentration Rate
3.6.2 Global 5 and 10 Largest Pharmacovigilance Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PHARMACOVIGILANCE INDUSTRY CHAIN ANALYSIS
4.1 Pharmacovigilance Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PHARMACOVIGILANCE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PHARMACOVIGILANCE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Pharmacovigilance Sales Market Share by Type (2019-2024)
6.3 Global Pharmacovigilance Market Size Market Share by Type (2019-2024)
6.4 Global Pharmacovigilance Price by Type (2019-2024)
7 PHARMACOVIGILANCE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Pharmacovigilance Market Sales by Application (2019-2024)
7.3 Global Pharmacovigilance Market Size (M USD) by Application (2019-2024)
7.4 Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
8 PHARMACOVIGILANCE MARKET SEGMENTATION BY REGION
8.1 Global Pharmacovigilance Sales by Region
8.1.1 Global Pharmacovigilance Sales by Region
8.1.2 Global Pharmacovigilance Sales Market Share by Region
8.2 North America
8.2.1 North America Pharmacovigilance Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Pharmacovigilance Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Pharmacovigilance Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Pharmacovigilance Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Pharmacovigilance Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Eli Lilly and Company
9.1.1 Eli Lilly and Company Pharmacovigilance Basic Information
9.1.2 Eli Lilly and Company Pharmacovigilance Product Overview
9.1.3 Eli Lilly and Company Pharmacovigilance Product Market Performance
9.1.4 Eli Lilly and Company Business Overview
9.1.5 Eli Lilly and Company Pharmacovigilance SWOT Analysis
9.1.6 Eli Lilly and Company Recent Developments
9.2 ICON
9.2.1 ICON Pharmacovigilance Basic Information
9.2.2 ICON Pharmacovigilance Product Overview
9.2.3 ICON Pharmacovigilance Product Market Performance
9.2.4 ICON Business Overview
9.2.5 ICON Pharmacovigilance SWOT Analysis
9.2.6 ICON Recent Developments
9.3 Elsevier
9.3.1 Elsevier Pharmacovigilance Basic Information
9.3.2 Elsevier Pharmacovigilance Product Overview
9.3.3 Elsevier Pharmacovigilance Product Market Performance
9.3.4 Elsevier Pharmacovigilance SWOT Analysis
9.3.5 Elsevier Business Overview
9.3.6 Elsevier Recent Developments
9.4 Chiltern
9.4.1 Chiltern Pharmacovigilance Basic Information
9.4.2 Chiltern Pharmacovigilance Product Overview
9.4.3 Chiltern Pharmacovigilance Product Market Performance
9.4.4 Chiltern Business Overview
9.4.5 Chiltern Recent Developments
9.5 Atlantic Research Group
9.5.1 Atlantic Research Group Pharmacovigilance Basic Information
9.5.2 Atlantic Research Group Pharmacovigilance Product Overview
9.5.3 Atlantic Research Group Pharmacovigilance Product Market Performance
9.5.4 Atlantic Research Group Business Overview
9.5.5 Atlantic Research Group Recent Developments
9.6 Mapi Group
9.6.1 Mapi Group Pharmacovigilance Basic Information
9.6.2 Mapi Group Pharmacovigilance Product Overview
9.6.3 Mapi Group Pharmacovigilance Product Market Performance
9.6.4 Mapi Group Business Overview
9.6.5 Mapi Group Recent Developments
9.7 Accenture
9.7.1 Accenture Pharmacovigilance Basic Information
9.7.2 Accenture Pharmacovigilance Product Overview
9.7.3 Accenture Pharmacovigilance Product Market Performance
9.7.4 Accenture Business Overview
9.7.5 Accenture Recent Developments
9.8 Clinquest Group
9.8.1 Clinquest Group Pharmacovigilance Basic Information
9.8.2 Clinquest Group Pharmacovigilance Product Overview
9.8.3 Clinquest Group Pharmacovigilance Product Market Performance
9.8.4 Clinquest Group Business Overview
9.8.5 Clinquest Group Recent Developments
9.9 GSK
9.9.1 GSK Pharmacovigilance Basic Information
9.9.2 GSK Pharmacovigilance Product Overview
9.9.3 GSK Pharmacovigilance Product Market Performance
9.9.4 GSK Business Overview
9.9.5 GSK Recent Developments
9.10 PRA Health Sciences
9.10.1 PRA Health Sciences Pharmacovigilance Basic Information
9.10.2 PRA Health Sciences Pharmacovigilance Product Overview
9.10.3 PRA Health Sciences Pharmacovigilance Product Market Performance
9.10.4 PRA Health Sciences Business Overview
9.10.5 PRA Health Sciences Recent Developments
10 PHARMACOVIGILANCE MARKET FORECAST BY REGION
10.1 Global Pharmacovigilance Market Size Forecast
10.2 Global Pharmacovigilance Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Pharmacovigilance Market Size Forecast by Country
10.2.3 Asia Pacific Pharmacovigilance Market Size Forecast by Region
10.2.4 South America Pharmacovigilance Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Pharmacovigilance by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Pharmacovigilance Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Pharmacovigilance by Type (2025-2030)
11.1.2 Global Pharmacovigilance Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Pharmacovigilance by Type (2025-2030)
11.2 Global Pharmacovigilance Market Forecast by Application (2025-2030)
11.2.1 Global Pharmacovigilance Sales (K Units) Forecast by Application
11.2.2 Global Pharmacovigilance Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacovigilance Market Size Comparison by Region (M USD)
Table 5. Global Pharmacovigilance Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmacovigilance Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmacovigilance Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmacovigilance Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance as of 2022)
Table 10. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmacovigilance Sales Sites and Area Served
Table 12. Manufacturers Pharmacovigilance Product Type
Table 13. Global Pharmacovigilance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmacovigilance
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacovigilance Market Challenges
Table 22. Global Pharmacovigilance Sales by Type (K Units)
Table 23. Global Pharmacovigilance Market Size by Type (M USD)
Table 24. Global Pharmacovigilance Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmacovigilance Sales Market Share by Type (2019-2024)
Table 26. Global Pharmacovigilance Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmacovigilance Market Size Share by Type (2019-2024)
Table 28. Global Pharmacovigilance Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmacovigilance Sales (K Units) by Application
Table 30. Global Pharmacovigilance Market Size by Application
Table 31. Global Pharmacovigilance Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmacovigilance Sales Market Share by Application (2019-2024)
Table 33. Global Pharmacovigilance Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmacovigilance Market Share by Application (2019-2024)
Table 35. Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmacovigilance Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmacovigilance Sales Market Share by Region (2019-2024)
Table 38. North America Pharmacovigilance Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmacovigilance Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmacovigilance Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmacovigilance Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmacovigilance Sales by Region (2019-2024) & (K Units)
Table 43. Eli Lilly and Company Pharmacovigilance Basic Information
Table 44. Eli Lilly and Company Pharmacovigilance Product Overview
Table 45. Eli Lilly and Company Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Eli Lilly and Company Business Overview
Table 47. Eli Lilly and Company Pharmacovigilance SWOT Analysis
Table 48. Eli Lilly and Company Recent Developments
Table 49. ICON Pharmacovigilance Basic Information
Table 50. ICON Pharmacovigilance Product Overview
Table 51. ICON Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. ICON Business Overview
Table 53. ICON Pharmacovigilance SWOT Analysis
Table 54. ICON Recent Developments
Table 55. Elsevier Pharmacovigilance Basic Information
Table 56. Elsevier Pharmacovigilance Product Overview
Table 57. Elsevier Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Elsevier Pharmacovigilance SWOT Analysis
Table 59. Elsevier Business Overview
Table 60. Elsevier Recent Developments
Table 61. Chiltern Pharmacovigilance Basic Information
Table 62. Chiltern Pharmacovigilance Product Overview
Table 63. Chiltern Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chiltern Business Overview
Table 65. Chiltern Recent Developments
Table 66. Atlantic Research Group Pharmacovigilance Basic Information
Table 67. Atlantic Research Group Pharmacovigilance Product Overview
Table 68. Atlantic Research Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Atlantic Research Group Business Overview
Table 70. Atlantic Research Group Recent Developments
Table 71. Mapi Group Pharmacovigilance Basic Information
Table 72. Mapi Group Pharmacovigilance Product Overview
Table 73. Mapi Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mapi Group Business Overview
Table 75. Mapi Group Recent Developments
Table 76. Accenture Pharmacovigilance Basic Information
Table 77. Accenture Pharmacovigilance Product Overview
Table 78. Accenture Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Accenture Business Overview
Table 80. Accenture Recent Developments
Table 81. Clinquest Group Pharmacovigilance Basic Information
Table 82. Clinquest Group Pharmacovigilance Product Overview
Table 83. Clinquest Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Clinquest Group Business Overview
Table 85. Clinquest Group Recent Developments
Table 86. GSK Pharmacovigilance Basic Information
Table 87. GSK Pharmacovigilance Product Overview
Table 88. GSK Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GSK Business Overview
Table 90. GSK Recent Developments
Table 91. PRA Health Sciences Pharmacovigilance Basic Information
Table 92. PRA Health Sciences Pharmacovigilance Product Overview
Table 93. PRA Health Sciences Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. PRA Health Sciences Business Overview
Table 95. PRA Health Sciences Recent Developments
Table 96. Global Pharmacovigilance Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Pharmacovigilance Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Pharmacovigilance Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Pharmacovigilance Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Pharmacovigilance Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Pharmacovigilance Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Pharmacovigilance Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Pharmacovigilance Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Pharmacovigilance Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Pharmacovigilance Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Pharmacovigilance Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Pharmacovigilance Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Pharmacovigilance Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Pharmacovigilance Market Size Comparison by Region (M USD)
Table 5. Global Pharmacovigilance Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Pharmacovigilance Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Pharmacovigilance Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Pharmacovigilance Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacovigilance as of 2022)
Table 10. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Pharmacovigilance Sales Sites and Area Served
Table 12. Manufacturers Pharmacovigilance Product Type
Table 13. Global Pharmacovigilance Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Pharmacovigilance
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Pharmacovigilance Market Challenges
Table 22. Global Pharmacovigilance Sales by Type (K Units)
Table 23. Global Pharmacovigilance Market Size by Type (M USD)
Table 24. Global Pharmacovigilance Sales (K Units) by Type (2019-2024)
Table 25. Global Pharmacovigilance Sales Market Share by Type (2019-2024)
Table 26. Global Pharmacovigilance Market Size (M USD) by Type (2019-2024)
Table 27. Global Pharmacovigilance Market Size Share by Type (2019-2024)
Table 28. Global Pharmacovigilance Price (USD/Unit) by Type (2019-2024)
Table 29. Global Pharmacovigilance Sales (K Units) by Application
Table 30. Global Pharmacovigilance Market Size by Application
Table 31. Global Pharmacovigilance Sales by Application (2019-2024) & (K Units)
Table 32. Global Pharmacovigilance Sales Market Share by Application (2019-2024)
Table 33. Global Pharmacovigilance Sales by Application (2019-2024) & (M USD)
Table 34. Global Pharmacovigilance Market Share by Application (2019-2024)
Table 35. Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
Table 36. Global Pharmacovigilance Sales by Region (2019-2024) & (K Units)
Table 37. Global Pharmacovigilance Sales Market Share by Region (2019-2024)
Table 38. North America Pharmacovigilance Sales by Country (2019-2024) & (K Units)
Table 39. Europe Pharmacovigilance Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Pharmacovigilance Sales by Region (2019-2024) & (K Units)
Table 41. South America Pharmacovigilance Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Pharmacovigilance Sales by Region (2019-2024) & (K Units)
Table 43. Eli Lilly and Company Pharmacovigilance Basic Information
Table 44. Eli Lilly and Company Pharmacovigilance Product Overview
Table 45. Eli Lilly and Company Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Eli Lilly and Company Business Overview
Table 47. Eli Lilly and Company Pharmacovigilance SWOT Analysis
Table 48. Eli Lilly and Company Recent Developments
Table 49. ICON Pharmacovigilance Basic Information
Table 50. ICON Pharmacovigilance Product Overview
Table 51. ICON Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. ICON Business Overview
Table 53. ICON Pharmacovigilance SWOT Analysis
Table 54. ICON Recent Developments
Table 55. Elsevier Pharmacovigilance Basic Information
Table 56. Elsevier Pharmacovigilance Product Overview
Table 57. Elsevier Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Elsevier Pharmacovigilance SWOT Analysis
Table 59. Elsevier Business Overview
Table 60. Elsevier Recent Developments
Table 61. Chiltern Pharmacovigilance Basic Information
Table 62. Chiltern Pharmacovigilance Product Overview
Table 63. Chiltern Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Chiltern Business Overview
Table 65. Chiltern Recent Developments
Table 66. Atlantic Research Group Pharmacovigilance Basic Information
Table 67. Atlantic Research Group Pharmacovigilance Product Overview
Table 68. Atlantic Research Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Atlantic Research Group Business Overview
Table 70. Atlantic Research Group Recent Developments
Table 71. Mapi Group Pharmacovigilance Basic Information
Table 72. Mapi Group Pharmacovigilance Product Overview
Table 73. Mapi Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. Mapi Group Business Overview
Table 75. Mapi Group Recent Developments
Table 76. Accenture Pharmacovigilance Basic Information
Table 77. Accenture Pharmacovigilance Product Overview
Table 78. Accenture Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Accenture Business Overview
Table 80. Accenture Recent Developments
Table 81. Clinquest Group Pharmacovigilance Basic Information
Table 82. Clinquest Group Pharmacovigilance Product Overview
Table 83. Clinquest Group Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Clinquest Group Business Overview
Table 85. Clinquest Group Recent Developments
Table 86. GSK Pharmacovigilance Basic Information
Table 87. GSK Pharmacovigilance Product Overview
Table 88. GSK Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. GSK Business Overview
Table 90. GSK Recent Developments
Table 91. PRA Health Sciences Pharmacovigilance Basic Information
Table 92. PRA Health Sciences Pharmacovigilance Product Overview
Table 93. PRA Health Sciences Pharmacovigilance Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. PRA Health Sciences Business Overview
Table 95. PRA Health Sciences Recent Developments
Table 96. Global Pharmacovigilance Sales Forecast by Region (2025-2030) & (K Units)
Table 97. Global Pharmacovigilance Market Size Forecast by Region (2025-2030) & (M USD)
Table 98. North America Pharmacovigilance Sales Forecast by Country (2025-2030) & (K Units)
Table 99. North America Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 100. Europe Pharmacovigilance Sales Forecast by Country (2025-2030) & (K Units)
Table 101. Europe Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 102. Asia Pacific Pharmacovigilance Sales Forecast by Region (2025-2030) & (K Units)
Table 103. Asia Pacific Pharmacovigilance Market Size Forecast by Region (2025-2030) & (M USD)
Table 104. South America Pharmacovigilance Sales Forecast by Country (2025-2030) & (K Units)
Table 105. South America Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 106. Middle East and Africa Pharmacovigilance Consumption Forecast by Country (2025-2030) & (Units)
Table 107. Middle East and Africa Pharmacovigilance Market Size Forecast by Country (2025-2030) & (M USD)
Table 108. Global Pharmacovigilance Sales Forecast by Type (2025-2030) & (K Units)
Table 109. Global Pharmacovigilance Market Size Forecast by Type (2025-2030) & (M USD)
Table 110. Global Pharmacovigilance Price Forecast by Type (2025-2030) & (USD/Unit)
Table 111. Global Pharmacovigilance Sales (K Units) Forecast by Application (2025-2030)
Table 112. Global Pharmacovigilance Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Pharmacovigilance
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance Market Size (M USD), 2019-2030
Figure 5. Global Pharmacovigilance Market Size (M USD) (2019-2030)
Figure 6. Global Pharmacovigilance Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance Market Size by Country (M USD)
Figure 11. Pharmacovigilance Sales Share by Manufacturers in 2023
Figure 12. Global Pharmacovigilance Revenue Share by Manufacturers in 2023
Figure 13. Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmacovigilance Market Share by Type
Figure 18. Sales Market Share of Pharmacovigilance by Type (2019-2024)
Figure 19. Sales Market Share of Pharmacovigilance by Type in 2023
Figure 20. Market Size Share of Pharmacovigilance by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmacovigilance by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmacovigilance Market Share by Application
Figure 24. Global Pharmacovigilance Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmacovigilance Sales Market Share by Application in 2023
Figure 26. Global Pharmacovigilance Market Share by Application (2019-2024)
Figure 27. Global Pharmacovigilance Market Share by Application in 2023
Figure 28. Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmacovigilance Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmacovigilance Sales Market Share by Country in 2023
Figure 32. U.S. Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmacovigilance Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmacovigilance Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmacovigilance Sales Market Share by Country in 2023
Figure 37. Germany Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmacovigilance Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmacovigilance Sales Market Share by Region in 2023
Figure 44. China Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmacovigilance Sales and Growth Rate (K Units)
Figure 50. South America Pharmacovigilance Sales Market Share by Country in 2023
Figure 51. Brazil Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmacovigilance Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmacovigilance Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmacovigilance Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmacovigilance Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmacovigilance Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmacovigilance Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmacovigilance Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmacovigilance Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Pharmacovigilance
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Pharmacovigilance Market Size (M USD), 2019-2030
Figure 5. Global Pharmacovigilance Market Size (M USD) (2019-2030)
Figure 6. Global Pharmacovigilance Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Pharmacovigilance Market Size by Country (M USD)
Figure 11. Pharmacovigilance Sales Share by Manufacturers in 2023
Figure 12. Global Pharmacovigilance Revenue Share by Manufacturers in 2023
Figure 13. Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Pharmacovigilance Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Pharmacovigilance Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Pharmacovigilance Market Share by Type
Figure 18. Sales Market Share of Pharmacovigilance by Type (2019-2024)
Figure 19. Sales Market Share of Pharmacovigilance by Type in 2023
Figure 20. Market Size Share of Pharmacovigilance by Type (2019-2024)
Figure 21. Market Size Market Share of Pharmacovigilance by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Pharmacovigilance Market Share by Application
Figure 24. Global Pharmacovigilance Sales Market Share by Application (2019-2024)
Figure 25. Global Pharmacovigilance Sales Market Share by Application in 2023
Figure 26. Global Pharmacovigilance Market Share by Application (2019-2024)
Figure 27. Global Pharmacovigilance Market Share by Application in 2023
Figure 28. Global Pharmacovigilance Sales Growth Rate by Application (2019-2024)
Figure 29. Global Pharmacovigilance Sales Market Share by Region (2019-2024)
Figure 30. North America Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Pharmacovigilance Sales Market Share by Country in 2023
Figure 32. U.S. Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Pharmacovigilance Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Pharmacovigilance Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Pharmacovigilance Sales Market Share by Country in 2023
Figure 37. Germany Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Pharmacovigilance Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Pharmacovigilance Sales Market Share by Region in 2023
Figure 44. China Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Pharmacovigilance Sales and Growth Rate (K Units)
Figure 50. South America Pharmacovigilance Sales Market Share by Country in 2023
Figure 51. Brazil Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Pharmacovigilance Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Pharmacovigilance Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Pharmacovigilance Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Pharmacovigilance Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Pharmacovigilance Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Pharmacovigilance Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Pharmacovigilance Market Share Forecast by Type (2025-2030)
Figure 65. Global Pharmacovigilance Sales Forecast by Application (2025-2030)
Figure 66. Global Pharmacovigilance Market Share Forecast by Application (2025-2030)
